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Abstract Baeyer^Villiger monooxygenases (BVMOs) form a
distinct class of flavoproteins that catalyze the insertion of an
oxygen atom in a C^C bond using dioxygen and NAD(P)H.
Using newly characterized BVMO sequences, we have uncovered
a BVMO-identifying sequence motif : FXGXXXHXXXW(P/D).
Studies with site-directed mutants of 4-hydroxyacetophenone
monooxygenase from Pseudomonas fluorescens ACB suggest
that this fingerprint sequence is critically involved in catalysis.
Further sequence analysis showed that the BVMOs belong to
a novel superfamily that comprises three known classes of
FAD-dependent monooxygenases: the so-called flavin-contain-
ing monooxygenases (FMOs), the N-hydroxylating mono-
oxygenases (NMOs), and the BVMOs. Interestingly, FMOs
contain an almost identical sequence motif when compared to the
BVMO sequences: FXGXXXHXXX(Y/F). Using these novel
amino acid sequence fingerprints, BVMOs and FMOs can be
readily identified in the protein sequence databank. ß 2002
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Baeyer^Villiger monooxygenases (BVMOs) are £avoen-
zymes that are able to catalyze a Baeyer^Villiger reaction;
using dioxygen and NAD(P)H a ketone function is converted
into the corresponding ester (Scheme 1) [1].
Cyclohexanone monooxygenase from Acinetobacter
NCIMB 9871 is the best characterized BVMO [2,3]. Because
of its wide substrate spectrum and stereoselectivity this en-
zyme has been extensively used for synthetic applications
[1,4]. Like other £avoprotein monooxygenases, cyclohexanone
monooxygenase forms a hydroperoxy£avin intermediate
which is involved in substrate oxygenation [5,6].
Until a few years ago, cyclohexanone monooxygenase was
the only BVMO of which the sequence was known. Recently,
several other bacterial BVMOs were cloned and sequenced:
4-hydroxyacetophenone monooxygenase [7], steroid monoox-
ygenase [8], cyclododecanone monooxygenase [9] and two
other cyclohexanone monooxygenases [10]. Using these data
we performed a sequence alignment study which uncovered a
conserved sequence motif. The function of this BVMO-specif-
ic sequence motif was explored by site-directed mutagenesis of
4-hydroxyacetophenone monooxygenase. Moreover, our
search for the presence of conserved sequence motifs also
resulted in the disclosure of a superfamily of sequence-related
FAD-dependent monooxygenases.
2. Materials and methods
2.1. Materials
Chemicals were purchased from Acros Chimica, Merck, Aldrich, or
Sigma. Molecular biology enzymes were purchased from Roche. Oli-
gonucleotides were supplied by Eurosequence BV, Groningen, The
Netherlands.
2.2. Site-directed mutagenesis
The Quickchange site-directed mutagenesis kit from Stratagene was
used to introduce mutations into the 4-hydroxyacetophenone mono-
oxygenase gene. Successful mutagenesis was con¢rmed by plasmid
sequencing. Mutant proteins were expressed and puri¢ed as described
for wild type enzyme [7].
2.3. Analytical methods
4-Hydroxyacetophenone monooxygenase activity was determined
as described previously [7]. The relative molecular mass of native
4-hydroxyacetophenone monooxygenase was determined by FPLC
gel ¢ltration using a Superdex 200 HR 10/30 column (Pharmacia
Biotech) running with 50 mM potassium phosphate bu¡er, pH 7.5.
Absorption spectra were recorded at 25‡C on a Perkin Elmer Lambda
Bio 40 spectrophotometer. Circular dichroism (CD) spectra were re-
corded at 25‡C from 190 to 250 nm using a 0.1-cm cuvette containing
0.1 mg/ml of enzyme (5 mM potassium phosphate, pH 7.5), and an
AVIV 62A DS spectrometer.
2.4. Sequence homology analysis
The BLAST programs at the National Center for Biotechnology
Information (www.ncbi.nlm.nih.gov/BLAST/) were used to search
for proteins showing sequence similarity. Multiple sequence align-
ments were made with the ClustalW program at the Centre for Mo-
lecular and Biomolecular Informatics (www.cmbi.kun.nl/bioinf/tools).
Sequence alignments were visualized using the BOXSHADE 3.21
program (http://www.ch.embnet.org/software/BOX_form.html). Tree-
View 1.5.2 was used for generating a tree representation using the
ClustalW output.
3. Results and discussion
3.1. The BVMO family
A non-redundant database search at the NCBI using the
protein sequence of 4-hydroxyacetophenone monooxygenase
and the BLASTP program [11] yielded 35 protein sequences
with signi¢cant similarity (Ss 100, E6 1.10320). Besides the
above-mentioned bacterial BVMOs (sequence identities of 27^
33%), this set of homologs contains two fungal gene products
that have been shown to be involved in biosynthetic pathways
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of mycotoxins which include Baeyer^Villiger oxidation steps
[12,13]. All BVMO homologs found are of bacterial or fungal
origin, indicating that BVMOs play a role in a variety of
microbial oxidative metabolic pathways. Interestingly, a rela-
tively large number of BVMO homologs was found in patho-
genic bacteria (e.g. seven in Mycobacterium tuberculosis
H37Rv). In addition, by performing a BLAST search in the
NCBI database of patented nucleotide sequences we found
that a DNA probe (accession nr. L04542) used for speci¢c
detection of pathogenic Mycobacterium avium isolates [14] en-
codes a major part of a putative BVMO (35% sequence iden-
tity). This indicates that these oxidative enzymes represent
attractive targets for drug development. In fact, one of the
seven BVMO-related genes from M. tuberculosis, was recently
shown to be responsible for the activation and therefore the
e⁄cacy of the widely used anti-tuberculosis pro-drug ethiona-
mide [15,16]. It has been shown that the etaA gene product
mediates ethionamide activation by sulfoxidation; a reaction
typically catalyzed by BVMOs.
Alignment of the BVMO homologs revealed several con-
served regions containing sequence motifs that are known to
be involved in dinucleotide cofactor binding [17]. The con-
served sequence motifs can also be clearly recognized from
the alignment of all above-mentioned biochemically identi¢ed
BVMOs, as shown in Fig. 1. The presence of two Rossmann
folds, as evidenced by two GXGXX(G/A) motifs, clearly dis-
criminates these enzymes from the mechanistically related £a-
voprotein hydroxylases [18]. Furthermore, we noticed a
stretch of conserved residues just before the second Rossmann
fold motif. With two exceptions, this FXGXXXHXXXW-
(P/D) motif is strictly conserved in all BVMO homologs and
represents, apart from the Rossmann fold motif regions, the
sequence region with the highest number of conserved resi-
dues. In the two aberrant protein sequences from Caulobacter
crescentus the central histidine is not conserved.
To probe the speci¢city of the BVMO sequence motif we
also used the motif as a seed for a Pattern Hit Initiated
BLAST search [19]. By this approach, the above-mentioned
sequences could be speci¢cally retrieved. Furthermore, a trawl
of the PEDANT genomic sequence database (http://pedant.
gsf.de/) using only the BVMO sequence motif as seed for
a pattern search resulted in the speci¢c identi¢cation of
32 microbial BVMO homologs. These pattern-based searches
exemplify the potential of the described sequence motif for
e⁄cient annotation of putative BVMO genes.
3.2. BVMOs are sequence-related to £avin-containing
monooxygenases (FMOs) and N-hydroxylating
monooxygenases (NMOs)
The sequential organization of the dinucleotide binding se-
quence motifs observed in known BVMO sequences is remi-
niscent of two other £avoprotein monooxygenase families:
multi-functional FMOs (eukaryotic enzymes oxygenating a
broad range of amines and other heteroatom containing com-
pounds) [20] and NMOs (microbial enzymes catalyzing N-hy-
droxylations of long-chain primary amines) [21]. A search in
the non-redundant database of NCBI using the PSI-BLAST
program [22] con¢rmed sequence homology between BVMOs,
FMOs and NMOs, revealing the presence of more than 150
sequences belonging to one of these three £avoprotein fami-
lies. Two representative members of the FMO and NMO
families have been included in the multiple sequence align-
ment depicted in Fig. 1. The observed sequence similarity
between members of the three di¡erent £avoprotein families
is re£ected in their structural and catalytic properties: all
characterized members are single-component FAD-containing
monooxygenases of about 50 kDa which speci¢cally use
NADPH as electron donor. A dendrogram of all homologous
sequences gives insight in the sequence distance relationship
within the discovered £avoprotein superfamily nicely illustrat-
ing the clustering of sequences in the three distinct monoox-
ygenase families (Fig. 2).
From the three monooxygenase families, members of the
FMO family have been most extensively studied as they
play an essential role in the detoxi¢cation of xenobiotics
(e.g. nicotine, drugs) in vertebrates [20]. Vertebrates typically
contain ¢ve FMO isoforms. Several naturally occurring mu-
tations in human FMO3 have been shown to underlie inher-
itable trimethylaminuria (also called ‘¢sh-odor syndrome’) il-
lustrating the important role of FMOs in metabolic
detoxi¢cation [23]. Except for the known mammalian
FMOs, our sequence similarity search revealed a surprising
number of FMO homologs in plants (26 in the Arabidopsis
thaliana genome). Recently, the function of three of these
homologs (YUCCA 1^3) has been identi¢ed, con¢rming a
FMO-type reactivity as these enzymes catalyze an N-oxygen-
ation of tryptamine yielding a precursor of the plant hormone
auxin [24]. Interestingly, in all FMO sequences a similar se-
quence motif as found for BVMOs can be identi¢ed,
FXGXXXHXXX(Y/F), di¡ering by only one residue (Fig.
1). Only in the FMO homologs from yeast this sequence sig-
nature is not fully conserved. In this respect it is interesting to
note that yeast FMO has lost its ability to catalyze typical
FMO reactions [25].
Scheme 1. Baeyer^Villiger reactions catalyzed by £avin-containing
BVMOs.
C
Fig. 1. Multiple sequence alignment of several members of the £avoprotein monooxygenase superfamily which includes several BVMOs (HAP-
MO: 4-hydroxyacetophenone monooxygenase from P. £uorescens ACB, AF355751; STMO: steroid monooxygenase from Rhodococcus rho-
dochrous, BAA24454; CHMO1^4: several bacterial cyclohexanone monooxygenases, P12015, AAG10021, AAG01289, AAG01290; CDMO: cy-
clododecanone monooxygenase from R. ruber, AAL14233; CPMO: cyclopentanone monooxygenase from Comamonas testosteroni, CAD10798;
ATMO: a£atoxin biosynthesis monooxygenase from Aspergillus parasiticus, AAF26281; SCMO: sterigmatocystin biosynthesis monooxygenase
from Aspergillus nidulans, Q00730; ETAM: ethionamide-activating monooxygenase from M. tuberculosis, CAB06212), a FMO (FMO3 from hu-
man, P31513), and an NMO (LNMO: L-lysine N6-hydroxylase from E. coli, P11295). The sequence of thioredoxin reductase (TR) from E. coli
(66129) is included in the alignment (active-site cysteines indicated by triangles). Common £avoprotein motifs [17] and the newly identi¢ed
BVMO sequence motif are indicated in the top line. For proper alignment some residues are not shown (in parentheses).
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Members of the NMO family have been less well studied
which is partly due to their low a⁄nity for the FAD cofactor
[26]. In NMO sequences, only the histidine appears to be
strictly conserved in the sequence region corresponding to
the location of the above-mentioned BVMO and FMO se-
quence motifs (Fig. 1) (see [27]). The conservation of this
histidine residue throughout the monooxygenase superfamily
indicates that it ful¢lls a role in a shared function within the
monooxygenase superfamily.
3.3. Probing the functional role of the newly identi¢ed
sequence motif
To examine the functional role of the BVMO-speci¢c se-
quence motif we performed a site-directed mutagenesis study
on 4-hydroxyacetophenone monooxygenase from Pseudomo-
nas £uorescens. This BVMO has recently been cloned and
characterized in our laboratory providing a good opportunity
to investigate the observed sequence conservation [7]. As tar-
gets for mutagenesis, the conserved His296 and Trp300 resi-
dues were chosen. Expression of both W300A and W300Y
mutant enzymes resulted in formation of insoluble and inac-
tive protein. This indicates that the conserved tryptophan
serves a critical role in attaining and/or maintaining a cor-
rectly folded state of the enzyme. The H296A mutant enzyme
was expressed in soluble form and could be puri¢ed using the
procedure used for wild type 4-hydroxyacetophenone mono-
oxygenase. However, during puri¢cation the mutant enzyme
lost its FAD cofactor to some extent. Holo H296A enzyme
could be obtained by saturating the apoprotein fraction with
FAD or by purifying the protein in the presence of 50 WM
FAD. Both procedures resulted in fully reconstituted H296A
as indicated by an A280/A440 ratio of 16.8 which is similar to
that observed for wild type enzyme. Gel ¢ltration experiments
revealed that, similar to wild type enzyme, the holo form of
the H296A mutant is present as a dimer. Furthermore, the
far-UV CD spectra of wild type 4-hydroxyacetophenone
monooxygenase and the H296A mutant were identical, indi-
cating that the mutation did not a¡ect overall protein folding.
Kinetic analysis revealed that the H296A mutant showed
nearly no activity (kcat6 0.01 s31). Moreover, the £avin spec-
tral properties of the H296A mutant were slightly di¡erent
from those of wild type 4-hydroxyacetophenone monooxyge-
Fig. 2. An unrooted phylogenetic tree of the £avoprotein monooxygenase superfamily. Sequences retrieved from the NCBI protein sequence da-
tabase using PSI-BLAST were used (January 21, 2002). A bar showing 10% divergence is included. In addition to the monooxygenases that are
discussed in the text some other annotated sequences are indicated (PNMO: putrescine hydroxylase from Bordetella bronchiseptica Q44740 [29];
DNMO: N4-diaminopropane monooxygenase from Sinorhizobium meliloti, AAK65920 [30]; ONMO1: L-ornithine N5-monooxygenase from Us-
tilago maydis, P56584 [31]; ONMO2: L-ornithine N5-monooxygenase from P. aeruginosa (Q51548) [32]; ONMO3: L-ornithine N5-monooxyge-
nase from Pseudomonas strain B10 (AAG27518) [26]). The clustering of the three monooxygenase families is indicated by gray shading. The ori-
gin of each sequence is indicated by color: animal (blue), plant (green), fungal (yellow), eubacterial (red), and archaebacterial (pink). The
accession numbers of all sequences can be found at http:/www.chem.rug.nl/biotechnology.
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nase. These data suggest that His296 is located in the vicinity
of the £avin cofactor site and is important for catalysis.
A sequence homology search in the protein structure data-
base (PDB) using the 4-hydroxyacetophenone monooxygenase
sequence gave a further hint to the functional role of the
newly identi¢ed ¢ngerprint sequence. Except for homology
with short stretches of sequences containing the typical
GXGXX(G/A) Rossmann fold ¢ngerprint only one protein
sequence in the PDB, that of thioredoxin reductase from Es-
cherichia coli, displayed sequence similarity covering a signi¢-
cant length of amino acids (23% sequence identity in 196
residues; see Fig. 1). Thioredoxin reductase is a member of
the NAD(P)H-dependent disul¢de oxidoreductase family of
homodimeric £avoenzymes [28]. In thioredoxin reductase,
the £avin cofactor is ¢rst reduced by NADPH, after which
the £avin transfers the electrons to the active-site disul¢de
formed by Cys135 and Cys138. From the alignment it can
be seen that the identi¢ed BVMO sequence motif aligns well
with the sequence region of thioredoxin reductase containing
the active-site cysteines. This supports the above proposal that
the newly identi¢ed sequence motif re£ects an essential struc-
tural element in the active site of BVMOs. Analogous to the
active-site cysteines in the disul¢de oxidoreductases, the con-
served histidine may ful¢ll a crucial role in catalysis in all
members of the identi¢ed monooxygenase superfamily
through a speci¢c interaction with the £avin cofactor.
Elucidation of the exact functional role of the observed se-
quence conservation awaits a crystallographic analysis of a
member of this novel £avoprotein monooxygenase superfam-
ily as no three-dimensional structure is available for any
BVMO, FMO or NMO. Nonetheless, the uncovered ¢nger-
print sequences unambiguously discriminate these enzymes
from the mechanistically related £avoprotein hydroxylases
and represent valuable tools for functional annotation of
genes in the steadily growing genomic sequence database.
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